title: Distinct and overlapping roles of Nipah virus P gene products in modulating the human endothelial cell antiviral response.
abstract: Nipah virus (NiV) is a highly pathogenic zoonotic paramyxovirus that causes fatal encephalitis in up to 75% of infected humans. Like other paramyxoviruses, NiV employs co-transcriptional mRNA editing during transcription of the phosphoprotein (P) gene to generate additional mRNAs encoding the V and W proteins. The C protein is translated from the P mRNA, but in an alternative reading frame. There is evidence from both in vitro and in vivo studies to show that the P gene products play a role in NiV pathogenesis. We have developed a reverse genetic system to dissect the individual roles of the NiV P gene products in limiting the antiviral response in primary human microvascular lung endothelial cells, which represent important targets in human NiV infection. By characterizing growth curves and early antiviral responses against a number of recombinant NiVs with genetic modifications altering expression of the proteins encoded by the P gene, we observed that multiple elements encoded by the P gene have both distinct and overlapping roles in modulating virus replication as well as in limiting expression of antiviral mediators such as IFN-β, CXCL10, and CCL5. Our findings corroborate observations from in vivo hamster infection studies, and provide molecular insights into the attenuation and the histopathology observed in hamsters infected with C, V, and W-deficient NiVs. The results of this study also provide an opportunity to verify the results of earlier artificial plasmid expression studies in the context of authentic viral infection.
authors.affiliation: Centers for Disease Control & Prevention, Viral Special Pathogens Branch, Atlanta, Georgia, United States of America. mko2@cdc.gov
authors.forename: Michael K
authors.initials: MK
authors.lastname: Lo
authors.forename: Mark E
authors.initials: ME
authors.lastname: Peeples
authors.forename: William J
authors.initials: WJ
authors.lastname: Bellini
authors.forename: Stuart T
authors.initials: ST
authors.lastname: Nichol
authors.forename: Paul A
authors.initials: PA
authors.lastname: Rota
authors.forename: Christina F
authors.initials: CF
authors.lastname: Spiropoulou
mesh_terms: D002460:Cell Line; D018946:Chemokine CCL5 / Q000096:biosynthesis / Q000276:immunology; D054357:Chemokine CXCL10 / Q000096:biosynthesis / Q000276:immunology; D042783:Endothelial Cells / Q000473:pathology / Q000821:virology*; D004730:Endothelium, Vascular / Q000473:pathology / Q000821:virology; D015967:Gene Expression Regulation, Viral; D045464:Henipavirus Infections / Q000276:immunology / Q000821:virology; D054884:Host-Pathogen Interactions; D006801:Humans; D016899:Interferon-beta / Q000096:biosynthesis / Q000276:immunology; D045405:Nipah Virus / Q000235:genetics* / Q000378:metabolism / Q000472:pathogenicity; D010750:Phosphoproteins / Q000235:genetics* / Q000378:metabolism; D061251:Primary Cell Culture; D012333:RNA, Messenger / Q000235:genetics* / Q000378:metabolism; D012367:RNA, Viral / Q000235:genetics*; D059386:Reverse Genetics; D014764:Viral Proteins / Q000235:genetics* / Q000378:metabolism; D014779:Virus Replication
chemical_list: C483024:CCL5 protein, human; C114753:CXCL10 protein, human; D018946:Chemokine CCL5; D054357:Chemokine CXCL10; D010750:Phosphoproteins; D012333:RNA, Messenger; D012367:RNA, Viral; D014764:Viral Proteins; D016899:Interferon-beta